NEWS: 公告在東京證券交易所JASDAQ標準市場新上市


全球OIS (腫瘤學資訊系統) 市場:成長,趨勢,及預測

Oncology Information System Market - Growth, Trends, and Forecasts (2020 - 2025)

出版商 Mordor Intelligence Pvt Ltd 商品編碼 922033
出版日期 內容資訊 英文 113 Pages
商品交期: 2-3個工作天內
全球OIS (腫瘤學資訊系統) 市場:成長,趨勢,及預測 Oncology Information System Market - Growth, Trends, and Forecasts (2020 - 2025)
出版日期: 2020年06月01日內容資訊: 英文 113 Pages

本報告提供全球OIS (腫瘤學資訊系統) 市場的相關調查,提供市場機會和趨勢,成長及阻礙因素,各產品及服務·用途·地區的市場分析,各終端用戶·地區的市場分析,競爭情形,主要企業的簡介等資訊。


第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 癌症發生率的全球化
    • 政府擴大致力提高對癌症的認識
  • 市場阻礙因素
    • 癌症治療的高成本
    • 缺乏熟練的專家
  • 波特的五力分析

第5章 市場區隔

  • 產品·各類服務
    • 軟體
    • 服務
  • 各用途
    • 醫療腫瘤學
    • 放射線腫瘤學
    • 外科腫瘤學
  • 各終端用戶
    • 醫院
    • 研究中心
    • 專門診所
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東·非洲階段
    • 南美

第6章 競爭情形

  • 企業簡介
    • Cerner Corporation
    • Varian Medical Systems
    • Elekta AB
    • CureMD Corporation
    • McKesson Corporation
    • Flatiron Health, Inc.
    • Accuray Incorporated
    • RaySearch Laboratories AB
    • BMSI Partners, Inc.

第7章 市場機會及今後趨勢


Product Code: 67544

The major factors attributing to the growth of the oncology information systems market include the rising incidence of cancer cases worldwide. A rise in the geriatric population is also propelling the demand for oncology information systems and driving the market growth.

Owing to the increasing number of specific therapies in the oncology pipeline, the number of late-stage pipeline therapies rose from 711 in 2017 to 849 in 2018 - an increase of 19% and the use of information systems help in managing the data of these therapies between the healthcare organization and treatment providers/patients are boosting the market growth.

There are few more factors which are playing crucial roles in taking the oncology information system market to the next level, among them OIS technological developments, including OIS benefits over traditional record-keeping, and on-going drug developments for new treatments, which are expected to further propel the growth of oncology information system market.

Key Market Trends

Software Segment is Expected to Hold the Largest Market Share in the Oncology Information System Market

The software segment has dominated the market owing to the increase in cancer patients globally and the tests associated with the examination and treatment of cancer patients. As per the statistics from GLOBOCAN 2018, there is an estimated 2,129,118 number of incident cases in the United States, in 2018, which is expected to grow by 2040 and reach a number of 3,096,944 cases. As the number of people with cancer will increase, keeping track of patient data and coordinating treatment plans is challenging for doctors and medical professionals. Softwares of oncology information systems can help medical professionals in keeping the track of all the information related to patient and their treatment. The oncology information system software helps physicians to improve the management of patient information.

North America Dominates the Market and is Expected to do Same in the Forecast Period

North America is expected to dominate the overall oncology information system market, throughout the forecast period. This is owing to factors such as the rising prevalence of cancer and the availability of advanced healthcare infrastructure among the major factors.

In North America region, the United States holds the largest market share owing to the factors such as increasing number of population suffering from cancer, along with the rising geriatric population and developments related to cancer therapy and rising government initiative for the awareness of cancer in the country, is anticipated to further drive the oncology information system market in this region.

Asia Pacific is also anticipated to register the fastest CAGR due to the high prevalence of cancer coupled with government initiatives and expenditure in the healthcare sector.

Competitive Landscape

The oncology information system market is moderately competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. And some prominent players are vigorously making acquisitions and joint ventures with the other companies to consolidate their market positions across the globe.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents


  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study




  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising incidence of Cancer Worldwide
    • 4.2.2 Growing Government Initiatives for Cancer Awareness
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Cancer Therapies
    • 4.3.2 Dearth of Skilled Professionals
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry


  • 5.1 By Product & Service
    • 5.1.1 Software
    • 5.1.2 Service
  • 5.2 By Application
    • 5.2.1 Medical Oncology
    • 5.2.2 Radiation Oncology
    • 5.2.3 Surgical Oncology
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Research Centers
    • 5.3.3 Specialty Clinics
  • 5.4 Geography
    • 5.4.1 North America
      • United States
      • Canada
      • Mexico
    • 5.4.2 Europe
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • Rest of Europe
    • 5.4.3 Asia-Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • GCC
      • South Africa
      • Rest of Middle-East and Africa
    • 5.4.5 South America
      • Brazil
      • Argentina
      • Rest of South America


  • 6.1 Company Profiles
    • 6.1.1 Cerner Corporation
    • 6.1.2 Varian Medical Systems
    • 6.1.3 Elekta AB
    • 6.1.4 CureMD Corporation
    • 6.1.5 McKesson Corporation
    • 6.1.6 Flatiron Health, Inc.
    • 6.1.7 Accuray Incorporated
    • 6.1.8 RaySearch Laboratories AB
    • 6.1.9 BMSI Partners, Inc.